Fabino Enterprises Ltd
FABINOFabino Enterprises Ltd
FABINO
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.57 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.49 | 6.67 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Fabino Enterprises Ltd is a pharmaceutical company in India offering a wide range of allopathic, herbal, and Covid-19 products, including food supplements and veterinary products.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2023 | FY 2024 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 3.38 | 21.39 | — | |||
Raw Materials | 2.43 | 20.20 | — | |||
| Power & Fuel Cost | 0.00 | 0.00 | ||||
| Employee Cost | 0.19 | 0.18 | ||||
| Selling & Administrative Expenses | 0.16 | 0.25 | ||||
| Operating & Other expenses | 0.55 | 0.63 | ||||
EBITDA | 0.05 | 0.13 | — | |||
| Depreciation/Amortization | 0.03 | 0.04 | — | |||
| PBIT | 0.02 | 0.09 | — | |||
| Interest & Other Items | 0.01 | 0.04 | — | |||
| PBT | 0.01 | 0.05 | — | |||
| Taxes & Other Items | 0.00 | 0.01 | — | |||
| Net Income | 0.01 | 0.04 | — | |||
| EPS | 0.05 | 0.19 | — | |||
| DPS | 0.00 | 0.00 | — | |||
| Payout ratio | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fabino Enterprises Ltd | 163.01 | 1.57 | — |
| Sun Pharmaceutical Industries Ltd | 46.13 | 6.58 | 0.73% |
| Cipla Ltd | 29.21 | 4.49 | 0.87% |
| Mankind Pharma Ltd | 62.91 | 12.57 | — |
Price Comparison
Compare FABINO with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
FABINO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeFabino Enterprises will hold a meeting of the Board of Directors of the Company on 21 October 2024.Powered by Capital Market - Live
Fabino Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 16 September 2024.Powered by Capital Market - Live
Fabino Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 16 September 2024.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant